home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Merck & Co (NY:MRK)

118.10 UNCHANGED

Streaming Delayed Price Updated: 7:00 PM EDT, Mar 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Merck & Co

< Previous 1 2

...

26 27 28 29 30 31 32 33 34

...

99 100 Next >

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co.

March 23, 2025

From Faruqi & Faruqi LLP

Via GlobeNewswire

2 Beaten-Down Stocks to Buy on the Dip ↗

March 22, 2025

Via The Motley Fool

“We’re In A Stock Pickers Market” ↗

March 22, 2025

Markets have been oscillating up and down for weeks, creating what resembles a sine wave pattern. As the analyst notes,

Via Talk Markets

Topics ETFs

Which Is The Healthiest Investment: Merck Or Pfizer ↗

March 21, 2025

Adeep dive into Merck and Pfizer, two of the biggest pharmaceutical companies out there.

Via Talk Markets

Topics Stocks / Equities

Merck & Co Unusual Options Activity For March 10 ↗

March 10, 2025

Via Benzinga

Pharmaceutical Firms Say UK Investment Is 'Unlikely' Unless Payment Levy Is Adressed ↗

March 21, 2025

UK pharma leaders warn excessive NHS levies threaten industry growth, urging the government to reform payments. The ABPI highlights declining UK R&D investment and falling global competitiveness.

Via Benzinga

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against FMC, TransMedics, Alarum, and Merck and Encourages Investors to Contact the Firm

March 20, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

ROSEN, LEADING INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRK

March 20, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co.

March 19, 2025

From Faruqi & Faruqi LLP

Via GlobeNewswire

Merck Data at ACC.25 Highlight Innovative Advancements and Commitment to Improving Outcomes for People Living with Cardiovascular Disease

March 19, 2025

From Merck & Co., Inc.

Via Business Wire

Merck & Co's Options: A Look at What the Big Money is Thinking ↗

March 18, 2025

Via Benzinga

Pliant Therapeutics' Investigational Cancer Drug Shows Antitumor Activity Across Multiple Tumor Types ↗

March 17, 2025

Pliant Therapeutics' PLN-101095 showed partial responses in ICI-refractory tumors, with a 50% ORR at the highest dose tested in its Phase 1 trial.

Via Benzinga

Why MERCK & CO. INC. (NYSE:MRK) qualifies as a good dividend investing stock. ↗

March 17, 2025

Balancing Dividends and Fundamentals: The Case of MERCK & CO. INC. (NYSE:MRK).

Via Chartmill

Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones? ↗

March 16, 2025

Via The Motley Fool

Topics Stocks

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co.

March 15, 2025

From Faruqi & Faruqi LLP

Via GlobeNewswire

A Closer Look at Merck & Co's Options Market Dynamics ↗

March 14, 2025

Via Benzinga

These S&P500 stocks are gapping in today's session ↗

March 14, 2025

Looking for opportunities in today's market? Check out the S&P500 gap up and gap down stocks on Friday and stay ahead of the market trends.

Via Chartmill

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRK

March 13, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

Inflation Isn’t Going Away, But These Sectors Don’t Care ↗

March 13, 2025

The CPI and PPI releases this week came in more or less at estimates - nothing to alarm the talking heads, anyway. They show inflation slowing down but not receding.

Via Talk Markets

Topics ETFs Economy Stocks / Equities

How Do Investors Really Feel About Merck & Co? ↗

March 12, 2025

Via Benzinga

Merck Plans Regulatory Submission For Two-Drug Regime For HIV Infection By Mid-2025 ↗

March 12, 2025

Merck's DOR/ISL met primary efficacy and safety goals in two Phase 3 HIV trials. Marketing applications are planned for mid-2025.

Via Benzinga

Merck Announces Positive Data from Phase 3 Trials that Show the Investigational, Once-Daily, Oral, Two-Drug Regimen of Doravirine/Islatravir (DOR/ISL) Maintained HIV-1 Viral Suppression at Week 48

March 12, 2025

From Merck & Co., Inc.

Via Business Wire

Merck Injects $1 Billion To Expand Vaccine Production In US ↗

March 11, 2025

Merck unveils a $1 billion vaccine manufacturing facility in Durham, North Carolina, expanding its U.S. production and research investments.

Via Benzinga

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co.

March 11, 2025

From Faruqi & Faruqi LLP

Via GlobeNewswire

Moderna: 4 Key Reasons the CEO Just Bought $5M in Shares

March 11, 2025

Moderna stock has fallen to levels not seen in 5 years, but the CEO just spent $5 million buying stock in the open market underscoring his optimism for gains.

Via MarketBeat

Merck Unveils New Facility to Increase Vaccine Production Capacity

March 11, 2025

From Merck & Co., Inc.

Via Business Wire

MERCK & CO., INC. (NYSE: MRK) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Merck & Co., Inc. Investors of Upcoming Deadline

March 10, 2025

From Bernstein Liebhard LLP

Via GlobeNewswire

Institutional Investors Bet $1B on These 4 Stocks—Should You?

March 09, 2025

Institutional investors snapped up at least $1 billion in shares of each of these four companies in Q4 of 2024 - should you buy as well?

Via MarketBeat

3 Magnificent S&P 500 Dividend Stocks Down 20% to 63% to Buy and Hold Forever ↗

March 09, 2025

Great investments are even better and more fruitful when you can buy them at a discount.

Via The Motley Fool

Topics Stocks

5 Top Stocks to Buy for March ↗

March 08, 2025

These 5 stocks look rather intriguing at current levels.

Via The Motley Fool

< Previous 1 2

...

26 27 28 29 30 31 32 33 34

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com